The use of oral contraceptive pill containing gestodene and ethinylestradiol – a case report Case report
Article Sidebar
Published:
Mar 31, 2016
Keywords:
oral contraceptive pill, gestodene, ethinylestradiol
Main Article Content
Abstract
A case of a 28-year-old woman seeking an acceptable way of contraception is described. Several methods including: etonogestrel-releasing subdermal implant, transdermal patch and second generation oral contraceptive pill (OCP) had unfavorable tolerance profile and were rejected by the patient. Third generation OCP containing gestodene proved to be well-tolerated and was accepted by the woman.
Article Details
How to Cite
Nowakowski , A. (2016). The use of oral contraceptive pill containing gestodene and ethinylestradiol – a case report. Medycyna Faktow (J EBM), 9(1(30), 70-73. Retrieved from https://journalsmededu.pl/index.php/jebm/article/view/2273
Issue
Section
Articles
Copyright © by Medical Education. All rights reserved.
References
1. Berek J., Novak E.: Ginekologia. Tom 1. Wydanie polskie. Medipage, Warszawa 2008.
2. Roumen F.J., Mishell D.R. Jr.: The contraceptive vaginal ring, NuvaRing(®), a decade after its introduction. Eur. J. Contracept Reprod. Health Care 2012; 17(6): 415-427.
3. Stanczyk F.Z., Archer D.F.: Gestodene: a review of its pharmacology, potency and tolerability in combined contraceptive preparations. Contraception 2014; 89(4): 242-252.
2. Roumen F.J., Mishell D.R. Jr.: The contraceptive vaginal ring, NuvaRing(®), a decade after its introduction. Eur. J. Contracept Reprod. Health Care 2012; 17(6): 415-427.
3. Stanczyk F.Z., Archer D.F.: Gestodene: a review of its pharmacology, potency and tolerability in combined contraceptive preparations. Contraception 2014; 89(4): 242-252.